INRIG JULA (Chief Medical Officer) sold 30.8% of their position (44.67K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.79M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+32.40K
Price / share
$8.93
Trade value
$289.29K
% of position
Common Stock
Shares
−25.39K
Price / share
$62.02
Trade value
$1.57M
% of position
Common Stock
Shares
−17.28K
Price / share
$62.62
Trade value
$1.08M
% of position
Common Stock
Shares
−1.60K
Price / share
$63.69
Trade value
$101.90K
% of position
Common Stock
Shares
−400.00
Price / share
$65.31
Trade value
$26.12K
% of position
Net shares
−12.28K
Net value
-$2.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | M · Option Exercise | +32.40K | $8.93 | $289.29K | 28.7% | 112.77K | 145.16K |
| Common Stock Direct | 9/15/2026 | S · Sale | −25.39K | $62.02 | $1.57M | 17.5% | 145.16K | 119.78K |
| Common Stock Direct | 9/15/2026 | S · Sale | −17.28K | $62.62 | $1.08M | 14.4% | 119.78K | 102.49K |
| Common Stock Direct | 9/15/2026 | S · Sale | −1.60K | $63.69 | $101.90K | 1.6% | 102.49K | 100.89K |
| Common Stock Direct | 9/15/2026 | S · Sale | −400.00 | $65.31 | $26.12K | 0.4% | 100.89K | 100.49K |
| Total | −12.28K | -$2.50M | ||||||
Employee stock option (right to buy)
Common Stock
32.40K shares
Shares
−32.40K
Strike price
8.93
Held after
43.60K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock32.40K shares | 9/15/2026 | M · Option Exercise | −32.40K | 8.93 | — | 43.60K |